Re: Farmas USA
MTP/GALE
*Midatech Agrees to Acquire Marketed Oncology Product, Zuplenz®, From Galena Biopharma,
"Midatech will pay a total up front consideration of $3.75 million in cash, with further cash payments, totalling up to $26 million, becoming payable if certain sales milestones are achieved, which are expected to be self-financed by milestone-generated cashflow. Following the Acquisition, Management expects cash reserves to be c.£16 million at the financial year-end. The transaction is expected to be completed on or prior to Thursday, December 24, 2015, subject to customary closing conditions."
Midatech es la misma que adquirió Dara Bioscences, no?
Saludos